I don't think there is any relevant data, because it's different.... For example, my riding, Brampton South, is a hub for diabetes. Maybe that does not impact other areas. It is the same with indigenous diabetes; it's as high as a mountain. It's not specific data out there. That's why I want us, as the health committee, to listen to the witnesses, because this is an epidemic. A lot dollars are going into it. It's inter-related to other diseases as well.
If in the three meetings we can listen to witnesses, then we can make a report on strategy to the House. In the meantime, the PBO, even though we can look into other jurisdictions, can do the analysis. Why don't we want to go with the PBO first? Because we already are giving a lot of work to the PBO for our pharmacare analysis, and we are waiting for the report.
The other issue we are talking about is Ms. Gladu's bill on sickle cell, and I think this is an important issue as well.